PROSHARE ADVISORS LLC – Regeneron Pharmaceuticals, Inc. Transaction History
PROSHARE ADVISORS LLC portfolio value:
$82.39M
portfolio value
PROSHARE ADVISORS LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -16.32% | -23.33K shares | -2.10M | $688.87 | 119.60K |
| Q2 2022 | share | Decrease | -30.99% | -64.19K shares | -60.17M | $591.13 | 142.93K |
| Q1 2022 | share | Decrease | -4.13% | -8.93K shares | 8.21M | $698.42 | 207.13K |
| Q4 2021 | share | Increase | +41.97% | 63.87K shares | 44.34M | $642.51 | 216.06K |
| Q3 2021 | share | Increase | +12.12% | 16.45K shares | 16.28M | $605.18 | 152.19K |
| Q2 2021 | share | Decrease | -3.07% | -4.30K shares | 9.55M | $558.54 | 135.74K |
| Q1 2021 | share | Increase | +15.73% | 19.03K shares | 7.79M | $473.14 | 140.04K |
| Q4 2020 | share | Increase | +15.78% | 16.49K shares | -45K | $483.11 | 121.01K |
| Q3 2020 | share | Increase | +21.70% | 18.63K shares | 4.94M | $559.78 | 104.52K |
| Q2 2020 | share | Increase | +16.18% | 11.95K shares | 17.46M | $623.65 | 85.88K |
| Q1 2020 | share | Decrease | -29.35% | -30.71K shares | -3.19M | $488.29 | 73.92K |
| Q4 2019 | share | Decrease | -0.42% | -442 shares | 10.14M | $375.48 | 104.64K |
| Q3 2019 | share | Increase | +2.83% | 2.89K shares | -2.83M | $277.4 | 105.08K |
| Q2 2019 | share | Decrease | -0.87% | -895 shares | -10.34M | $313 | 102.18K |
| Q1 2019 | share | Decrease | -2.06% | -2.16K shares | 3.01M | $410.62 | 103.08K |
| Q4 2018 | share | Increase | +14.51% | 13.33K shares | 2.17M | $373.5 | 105.25K |
| Q3 2018 | share | Decrease | -16.26% | -17.85K shares | -731K | $404.04 | 91.91K |
| Q2 2018 | share | Decrease | -6.15% | -7.19K shares | -2.40M | $344.99 | 109.76K |
| Q1 2018 | share | Increase | +0.11% | 130 shares | -3.64M | $344.36 | 116.96K |
| Q4 2017 | share | Increase | +17.08% | 17.04K shares | -694K | $375.96 | 116.83K |
| Q3 2017 | share | Increase | +11.73% | 10.47K shares | 754K | $447.12 | 99.78K |
| Q2 2017 | share | Increase | +3.51% | 3.02K shares | 10.42M | $491.14 | 89.30K |
| Q1 2017 | share | Decrease | -13.06% | -12.96K shares | -2.99M | $387.51 | 86.28K |
| Q4 2016 | share | Increase | +7.95% | 7.30K shares | -529K | $367.09 | 99.24K |
| Q3 2016 | share | Decrease | -21.18% | -24.70K shares | -3.77M | $402.02 | 91.94K |
| Q2 2016 | share | Increase | +1.21% | 1.39K shares | -807K | $349.23 | 116.64K |
| Q1 2016 | share | Decrease | -11.18% | -14.50K shares | -28.89M | $360.44 | 115.25K |